title: Cancer immunotherapy. Neo approaches to cancer vaccines.
authors.affiliation: Genentech, South San Francisco, CA 94080, USA.
authors.forename: Lélia
authors.initials: L
authors.lastname: Delamarre
authors.affiliation: Genentech, South San Francisco, CA 94080, USA. mellman.ira@gene.com.
authors.forename: Ira
authors.initials: I
authors.lastname: Mellman
authors.affiliation: Genentech, South San Francisco, CA 94080, USA.
authors.forename: Mahesh
authors.initials: M
authors.lastname: Yadav
mesh_terms: D000951:Antigens, Neoplasm / Q000276:immunology*; D019496:Cancer Vaccines / Q000627:therapeutic use*; D003713:Dendritic Cells / Q000637:transplantation*; D015789:HLA-A2 Antigen / Q000276:immunology*; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods*; D008545:Melanoma / Q000628:therapy*; D012878:Skin Neoplasms / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D015789:HLA-A2 Antigen